Mannkind: Overlooked Biotech With Excellent Prospects (Part III) [View article]
Then why are institutions selling heavy this year? Seems that they would be able to do much more research then you and make a better judgement.
On 2008 Jun 13 04:43 AM R.J Steffens wrote:
> "This was yet another obstacle to prescribing Exubera, especially > since most doctors treating diabetics (i.e. general practitioners > and internists) do not have pulmonary testing equipment in their > offices. On the other hand, Mannkind found no evidence of any drop > in lung function whatsoever in their clinical trials with Technosphere > Insulin." > > Mannkind has not reported detailed Phase III results, and did not > report the additional safety data at the ADA event like they stated > they planned on doing. The did have ana abstract showing absorbtion > occuring 8 minutes later for smokers then for non-smokers as measured > by "tmax". The FDA, in my opnion, would require a diabetic to undergo > pulmonary tests for technosphere (if it is ever approved). The diabetic > already is losing lung function due to the progression of the desease: > > > "(5) Chronic use of inhaled insulin may affect long-term pulmonary > function, while preexisting pulmonary dysfunction may alter the absorption > and bioavailability of inhaled insulin." > > www.ncbi.nlm.nih.gov/p... > > Another worth mentioning is Generex's Oral-lyn Buccal spray. Since > Oral-lyn also has a very rapid onset of action, and NO deposition > into the lungs, it seems as if it would be the choice amongst diabetics > between these two potential products. Technosphere is said to afford > low titration and Oral-lyn provides 1 U sprays as part of a fine > tune regimen. Technosphere has another large obstacle that Oral-lyn > does not- TI needs to be marketed as a product that does not cause > decreased lung function or lung cancer. Fair or not, that is a horrible > position to be in. I wish them well, and hope they all are approved > to give diabetics a new choice and lifestyle freedom. This is a freedom > they have in India with Oral-lyn. > > Best wishes. >
Sort by:
Latest | Highest ratedDigitaltradz [View instapost]
Mannkind: Overlooked Biotech With Excellent Prospects (Part III) [View article]
On 2008 Jun 13 04:43 AM R.J Steffens wrote:
> "This was yet another obstacle to prescribing Exubera, especially
> since most doctors treating diabetics (i.e. general practitioners
> and internists) do not have pulmonary testing equipment in their
> offices. On the other hand, Mannkind found no evidence of any drop
> in lung function whatsoever in their clinical trials with Technosphere
> Insulin."
>
> Mannkind has not reported detailed Phase III results, and did not
> report the additional safety data at the ADA event like they stated
> they planned on doing. The did have ana abstract showing absorbtion
> occuring 8 minutes later for smokers then for non-smokers as measured
> by "tmax". The FDA, in my opnion, would require a diabetic to undergo
> pulmonary tests for technosphere (if it is ever approved). The diabetic
> already is losing lung function due to the progression of the desease:
>
>
> "(5) Chronic use of inhaled insulin may affect long-term pulmonary
> function, while preexisting pulmonary dysfunction may alter the absorption
> and bioavailability of inhaled insulin."
>
> www.ncbi.nlm.nih.gov/p...
>
> Another worth mentioning is Generex's Oral-lyn Buccal spray. Since
> Oral-lyn also has a very rapid onset of action, and NO deposition
> into the lungs, it seems as if it would be the choice amongst diabetics
> between these two potential products. Technosphere is said to afford
> low titration and Oral-lyn provides 1 U sprays as part of a fine
> tune regimen. Technosphere has another large obstacle that Oral-lyn
> does not- TI needs to be marketed as a product that does not cause
> decreased lung function or lung cancer. Fair or not, that is a horrible
> position to be in. I wish them well, and hope they all are approved
> to give diabetics a new choice and lifestyle freedom. This is a freedom
> they have in India with Oral-lyn.
>
> Best wishes.
>